Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma

PaperCitations, authors & open-access status

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 20 citations, 2022 year and gold oa status.

20
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Jianghua Ding
Author
Zhaohui Leng
Author
Cancer, Hypoxia, and Metabolism
Topic
Cancer, Hypoxia, and Metabolism
Topic
Cancer, Lipids, and Metabolism
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account